Ruben Gonzalez is presenting “Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles” at the 2022 Drug & Medical Device Litigation Conference in New York City. The panel discussion will include:
- Looking Beyond Albrecht: Analyzing the potential implications of Dobbs v. Jackson Women’s Health Organization on future preemption battles involving state attempts to ban FDA-approved drugs
- Could the Court’s recent decision limiting the authority of the EPA potentially impact the FDA’s future ability to enforce their regulations in the drug and device space?
- Views from Supreme Court practitioners on how the current division in the Court is impacting their approach to argument and their decisions on appellate issues